Postpartum Depression and Your Thyroid: The Hidden Connection

In this article

Meet the experts

Charles M. Carlsen, MD, is a board-certified Obstetrician-Gynecologist and co-founder of Drsono.

Erik Larson, PMHNP-BC, is a psychiatric-Mental Health Nurse Practitioner - Board Certified, and owner of Larson Mental Health. 

‍
Postpartum depression isn’t a character flaw, a failure, or a sign of a “bad mom.” It’s a real, biologically driven medical condition—often treatable, sometimes preventable, and far more common than most people realize. 

In this article, take a look at postpartum depression, how it shows up, why thyroid issues like Hashimoto’s and hypothyroidism are an often‑missed trigger of postpartum depression, and what’s new in treatment—including the much buzzed‑about “two‑week pill.”

Postpartum depression (PPD) is a depressive episode that starts during pregnancy or anytime in the first year after birth, and it’s one of the most common medical complications of childbearing. Unlike the short‑lived “baby blues,” PPD is more intense, lasts longer than two weeks, and interferes with daily life and bonding with the baby. 

• Large studies estimate that around 1 in 7 birthing parents experience postpartum depression within the year around childbirth. In general, it’s estimated that around 500,000 new parents are diagnosed with PPD in the U.S each year. 
• PPD can begin in late pregnancy, soon after delivery, or several months later, which is one reason it’s easy to miss. 
• Clinicians use standard depression criteria (like those in the Diagnostic and Statistical Manual of Mental Disorders) adapted to the postpartum period: at least two weeks of depressed mood or loss of interest plus symptoms such as sleep and appetite changes, low energy, guilt, poor concentration, or suicidal thoughts. 

PPD exists on a spectrum of postpartum mood disorders, which also includes:

• Postpartum “baby blues” (maternity blues): mild mood swings, crying, irritability, and anxiety that begin a few days after birth and resolve on their own within about 10 days. 
• Postpartum anxiety: often co‑occurs with PPD and features intense worry, restlessness, and physical tension. 
• Postpartum psychosis: a rare emergency with hallucinations, delusions, confusion, and severe mood changes, usually in the first weeks after birth. 

If symptoms are intense, last more than two weeks, or make it hard to function, it’s no longer “just” baby blues and deserves immediate attention. 

PPD doesn’t look the same in everyone, and it doesn’t always look like “sadness.” Many new mothers describe it as feeling numb, terrified, or trapped rather than tearful.

Common emotional and cognitive symptoms include: 

• Persistent sadness, emptiness, or flatness
• Loss of interest or pleasure in things you used to enjoy
• Feeling overwhelmed, hopeless, or like you’re “in a fog”
• Constant worry, racing thoughts, or panic
• Irritability, anger, or feeling easily “set off”
• Feeling like a failure or that your baby would be better off without you
• Difficulty concentrating, remembering, or making decisions

In her Instagram post, Katie Unverferth, MD, a Reproductive Psychiatrist at UCLA Women’s Life Center, writes: “Postpartum depression doesn’t always look like sadness. In many cases, it’s actually an anxious depression. I often see patients who feel constantly on edge — worrying, ruminating, unable to sleep even when the baby is sleeping.” 

Physical and behavioral symptoms often overlap with “normal” new‑parent exhaustion, which makes PPD tricky to spot: 

• Major sleep disruption that isn’t only due to the baby (you can’t sleep even when the baby sleeps, or you can’t drag yourself out of bed)
• Big changes in appetite and weight—eating far more or far less than usual
• Severe fatigue that doesn’t improve with rest
• Reduced interest in self‑care, relationships, or sex
• Thoughts of hurting yourself or, rarely, the baby

Charles M. Carlsen, MD, a board-certified Obstetrician-Gynecologist explains some common signs: 

"There are some warning signs that make me suspect that my patient may be suffering from Postpartum Depression. First off, if my patient has no feelings for her baby, that’s a huge warning sign to me that she may be suffering from postpartum depression. Another sign that makes me suspect that my patient may be suffering from postpartum depression is if she expresses guilt towards her baby. Some patients may tell me that they feel like they’re just not a very good mother to their baby despite the fact that the baby is perfectly healthy."

A classic scenario: A new mother pushes through for weeks, telling herself “this is just what having a newborn is like,” even as she becomes more exhausted, hopeless, and detached. Screening tools like the Edinburgh Postnatal Depression Scale (EPDS) can help distinguish PPD from normal adjustment to life with a newborn. 

PPD is rarely caused by one single thing; it’s usually a “perfect storm” of biology, hormones, mental health history, and life stress. 

Key contributors include:

• Major hormonal shifts: Estrogen, progesterone, and stress‑hormone levels change dramatically during pregnancy and drop sharply after birth, affecting brain chemicals like serotonin, norepinephrine, and dopamine, which are involved in mood. 
• Stress system changes: The hypothalamic‑pituitary‑adrenal (HPA) axis is heavily stressed in late pregnancy, then recalibrates after delivery, sometimes in ways that increase vulnerability to mood symptoms. 
• Sleep deprivation: Fragmented sleep is nearly universal with a newborn; in vulnerable people, it can flip the switch into depression or anxiety. 
• Personal and family history: A previous history of depression, bipolar disorder, or anxiety, or a family history of these conditions, strongly increases risk. 
• Psychosocial stressors: Lack of support, financial strain, birth trauma, NICU stays, or relationship conflict can all add fuel to the fire. 

And here’s an important emerging piece of the puzzle: thyroid function and autoimmune thyroid disease—especially Hashimoto’s and postpartum thyroiditis—can significantly increase the risk of postpartum mood problems and are often overlooked. 

Thyroid function and autoimmune thyroid disease—especially Hashimoto’s and postpartum thyroiditis—can significantly increase the risk of postpartum mood problems and are often overlooked. 

Your thyroid is a small, butterfly‑shaped gland in the neck that profoundly affects energy, metabolism, brain function, and mood. When it’s underactive (hypothyroidism), symptoms often mimic or worsen depression: fatigue, weight gain, brain fog, constipation, cold intolerance, and low mood. 

Thyroid dysfunction is relatively common after pregnancy. Systematic reviews estimate that postpartum thyroid dysfunction affects up to 17% of women, with an overall prevalence of about 8% in the general postpartum population, much higher than the 3 to 4 percent seen in the general population. 

Several lines of research link thyroid autoimmunity to postpartum mood disorders:

• The main predictors of postpartum mood disorders include hypothyroidism, low‑normal thyroid hormone levels, and the presence of thyroid peroxidase (TPO) antibodies. 
• Meta‑analyses show that women with autoimmune thyroid conditions, including Hashimoto’s and the presence of thyroid autoantibodies, have higher rates of clinical depression overall. 
• One large analysis estimated that women with Hashimoto’s thyroiditis had about a 1.4–1.5 times higher risk of postpartum depressive symptoms than those without antibodies. 

In practical terms, that means a subset of postpartum depression cases may be driven, or at least significantly worsened, by an autoimmune thyroid process that is either undiagnosed or undertreated. 

In postpartum thyroiditis, the thyroid is attacked by the immune system, often in two phases: a brief hyperthyroid phase (anxiety, palpitations) followed by a longer hypothyroid phase (fatigue, depression, weight gain). 

A clinical study looking at women with postpartum thyroiditis found:

• Most cases had a hypothyroid phase, and around a quarter of all participants developed postpartum depression during follow‑up
• Depression rates were higher in women who developed postpartum thyroiditis than in those who did not

The authors concluded that because hypothyroidism is a potentially reversible cause of depression, women with postpartum depression should be screened for hypothyroidism and treated appropriately. 

Other research shows:

• Higher thyroid‑stimulating hormone (TSH) levels around delivery have been associated in some studies with increased PPD risk months later, suggesting even mild or “high‑normal” hypothyroid states might matter. 
• Lower free and total T4 levels in the third trimester correlate with higher postpartum depression scores, especially in women with a history of mood disorders. 

The upshot: thyroid autoimmunity (Hashimoto’s) and postpartum thyroiditis can quietly drive fatigue, brain fog, and low mood that get labeled as “just PPD” while the underlying hormone imbalance goes untreated. 

Because so many PPD symptoms overlap with normal postpartum life, formal screening is essential rather than relying on “gut feeling.” 

Clinicians may use:

• Edinburgh Postnatal Depression Scale (EPDS): a 10‑item questionnaire; scores above common cutoffs (such as 13) suggest possible PPD that needs further evaluation. (An online EPDS calculator is available)
• Other tools like the Beck Depression Inventory, PHQ‑9, or other postpartum depression screening scales 

Screening ideally starts during pregnancy and continues postpartum, because symptoms can emerge late, even up to a year after delivery. 

From a thyroid standpoint, experts recommending a more integrative approach suggest checking TSH, free T4, and thyroid antibodies (like TPO) in women with depression, strong fatigue, or other hypothyroid symptoms during pregnancy or postpartum, especially if they have a personal or family history of thyroid disease. 

Catching and treating hypothyroidism or Hashimoto’s in this context can be a game‑changer for mood, energy, and overall recovery. 

OB-GYN Dr. Charles Carlsen has thyroid on his radar with his postpartum patients:

"I always keep a close watch on my patients around six to twelve weeks after delivery because that’s when thyroid problems often emerge. If we can diagnose hypothyroidism early on, the difference that medication can make is huge. Many patients report that they can finally say that they feel like themselves again."

The “classic” pillars of PPD treatment are psychotherapy, antidepressant medications, and social support. These remain crucial—even as newer options emerge. 

Talk therapy

Evidence‑based psychotherapies for PPD include:

• Cognitive behavioral therapy (CBT) helps identify and shift unhelpful thought patterns and behaviors.
• Interpersonal therapy (IPT) focuses on role changes, relationships, grief, and support systems during the transition to parenthood.

Studies show that appropriate psychotherapy can significantly reduce postpartum depressive symptoms, especially when started early. 

Antidepressant medications

Selective serotonin reuptake inhibitors (SSRIs) and similar antidepressants are commonly used to treat PPD. 

• Many SSRIs (such as sertraline) have breastfeeding‑compatible data, and guidelines often recommend them when benefits outweigh risks. 
• Limitations: they can take several weeks to fully work, and some women do not get adequate relief or cannot tolerate side effects. 

Support, sleep, and practical help

Non‑pharmacologic “basics” are not glamorous but can be powerful:

• Protected sleep stretches (someone else does a night feed, or pumped milk/combination feeding is used strategically)
• Practical help with meals, chores, and childcare
• Peer support groups, in‑person or online, to reduce isolation and shame

These measures don’t replace medical treatment in moderate to severe PPD, but they can amplify its effectiveness and help prevent worsening. 

Scientists have long suspected that allopregnanolone, a naturally occurring metabolite of progesterone that modulates the brain’s GABA receptors, plays a role in perinatal mood. After childbirth, levels of this neurosteroid drop sharply, which may destabilize mood in some people. 

In 2023, the U.S. Food and Drug Administration approved zuranolone (brand name Zurzuvae), the first oral medication specifically indicated for the treatment of postpartum depression. Zuranolone is sometimes known as the “two-week pill,” because of the drug’s recommended 14-day course.

Key facts from clinical trials and regulatory reviews:

• Zuranolone is a neuroactive steroid and GABA‑A receptor positive allosteric modulator, designed to restore the calming effects of allopregnanolone on the brain’s stress and mood circuits. 
• In two randomized, double‑blind, placebo‑controlled trials, women with postpartum depression took zuranolone once daily for 14 days.^‍
• By day 15 (the end of treatment), they had significantly greater improvement in depression scores (measured by the 17‑item Hamilton Depression Rating Scale) than those on placebo.
• The benefits were maintained through at least day 42—four weeks after the last dose—suggesting a durable effect after just a two‑week course.^‍
• The recommended dose is 50 mg once nightly for 14 days, taken with a fatty meal.

Side effects in studies included sleepiness, dizziness, fatigue, and, in some cases, sleep disturbance or infection, and the drug is dispensed with safety guidance on activities requiring alertness.^‍

A recent Rewire News Group feature looked at zuranolone’s real‑world uptake several years after its approval and posed exactly that question: if we finally have an oral, rapid‑acting PPD medication, why is usage so low? 

Some of the reasons discussed include: 

• Awareness gaps: Many obstetric and primary care providers, as well as patients, remain unfamiliar with zuranolone or unsure when and how to prescribe it.‍
• Insurance and access hurdles: Prior authorizations, uncertain coverage, and high costs can delay or prevent access, especially for low‑income patients. Note: Without health insurance coverage, Zurzurvae costs around $16,000 for a two-week treatment course. If covered, co-pays can also be high, but the manufacturer offers a discount coupon card to help reduce the cost for patients with commercial insurance.   ‍
• Stigma and fear: Parents may worry about being judged, losing custody, or being seen as “unsafe” if they admit to severe depression or intrusive thoughts—so they don’t seek care or ask about new treatments. ‍
• Preference for familiar options: Some clinicians default to SSRIs and therapy because they know them well, despite zuranolone’s faster onset and PPD‑specific evidence. 

The Rewire article underscores that approving a new drug is only the first step; true impact requires education, coverage, and systems that make it easy to screen and treat PPD early. 

Erik Larson, PMHNP-BC is a board-certified Psychiatric-Mental Health Nurse Practitioner. He shared with Paloma another reason why many women first receive treatment with SSRI’s:

“The prescribing information for zuranolone recommends avoiding breastfeeding during treatment and for several days after finishing the course. This poses a problem for breastfeeding women.” 

When a patient has postpartum depression symptoms plus possible thyroid clues—like severe fatigue, feeling cold, dry skin, hair loss beyond typical shedding, constipation, weight changes beyond expected postpartum shifts, or a history of an autoimmune disorder— evaluation of the thyroid gland becomes crucial. 

PPD expert Erik Larson also outlines some other common signs and symptoms: 

“When a woman presents with symptoms of depressed mood after giving birth, it’s important to consider the possible role of the thyroid early on, especially if there is severe fatigue, cognitive slowing, increased anxiety, palpitations, cold intolerance, constipation, or excessive hair loss. The risk is higher if there is a history of thyroid disease or autoimmune conditions, including Hashimoto’s disease.” 

What the research suggests:

• Autoimmune thyroiditis and hypothyroidism have a demonstrated correlation with depression in general, and multiple studies show a specific connection with postpartum depressive symptoms. 
• TPO‑positive women in late pregnancy are at significantly higher risk of postpartum thyroiditis and late‑onset depression. 
• In one cohort, PPD prevalence rose in women who developed postpartum thyroiditis compared with those who did not, reinforcing thyroid dysfunction as a modifiable factor.

Practical implications

• Thyroid screening: Checking TSH, free T4, and thyroid antibodies in women with PPD—especially if symptoms appear months after delivery or are accompanied by physical hypothyroid signs—can uncover a treatable thyroid driver. 
• Treatment: If hypothyroidism is confirmed, levothyroxine (thyroid hormone replacement) can correct the hormone deficit, often improving energy, cognition, and mood over the course of weeks. 
• Ongoing monitoring: In postpartum thyroiditis, some women recover normal function, while a minority progress to permanent hypothyroidism; both mood and thyroid hormone levels need follow‑up. 

For a subset of patients, this means that “postpartum depression” is not just in their head—it’s also in their thyroid. Addressing both the mood and endocrine aspects gives them the best chance at full recovery. 

If you or someone you love is struggling after having a baby, here are concrete steps to consider (alongside emergency help if there are any thoughts of self‑harm or harming the baby).

Take symptoms seriously

Take symptoms seriously, even if they seem “expected.” If sadness, anxiety, numbness, or exhaustion are intense, persistent, or interfering with daily life or bonding, it’s time to talk to a clinician. 

Get a formal PPD screening

Ask for formal screening with a postpartum depression questionnaire (like the EPDS) rather than brushing symptoms off as “just baby blues.” 

Get a complete thyroid panel

Request a thyroid workup—TSH, free T4, free T3, and thyroid antibodies—if you have mood symptoms plus fatigue, cold intolerance, hair loss, weight gain, or a history of thyroid problems or other autoimmune conditions. 

Discuss all treatment options

Working with your provider, review all your treatment options, including therapy, SSRIs, and whether you might be a candidate for a course of zuranolone. 

While OB-GYN Dr. Charles Carlsen does recommend newer treatments for some patients, he finds that "other postpartum women do well with traditional treatment. Selective serotonin reuptake inhibitors like Sertraline have been well studied for their safety in breastfeeding mothers. Psychotherapy is also a very effective treatment."

PPD expert Erik Larson recommends close communication between the practitioner and the patient when evaluating PPD treatment options. 

“When discussing postpartum treatment options, I try to make decisions collaboratively with the patient, considering the severity of symptoms, how quickly relief is needed, previous treatment experiences, breastfeeding plans, and the support she has at home. For many patients, psychotherapy and SSRIs are often the first step because they are more accessible, better studied, and easier to integrate into everyday life.”

Build a support team

Create a support network that includes your partner, family, friends, peer support groups, lactation help, and practical assistance so you’re not doing this alone. 

For many years, postpartum depression was treated primarily as a psychological condition. While therapy, medication, and social support remain essential, emerging research is reshaping how clinicians understand and treat postpartum mood disorders. Scientists now recognize that biological factors—including neurosteroid fluctuations and thyroid autoimmunity—play a much larger role than previously understood. This deeper understanding is opening the door to more targeted and effective treatments.

One promising development is the emergence of neurosteroid-based medications such as zuranolone, the first oral drug specifically approved to treat postpartum depression. Unlike traditional antidepressants that may take weeks to work, neurosteroid treatments act on GABA receptors in the brain—key regulators of stress and emotional stability. Clinical trials have shown that a short two-week course can significantly reduce depressive symptoms in some women, potentially offering faster relief during a time when early recovery is critical for both parent and baby.

At the same time, researchers are increasingly recognizing the impact of thyroid health on postpartum mood. Autoimmune thyroid disease, including postpartum thyroiditis and Hashimoto’s disease, can quietly trigger fatigue, brain fog, anxiety, and depression during the postpartum period. Because these symptoms overlap so closely with postpartum depression, thyroid dysfunction has often been overlooked. More clinicians are now recommending thyroid screening—such as testing TSH, free T4, and thyroid antibodies—in women with postpartum mood symptoms.

Looking ahead, the future of postpartum depression care will likely involve a more integrated, whole-body approach. This means combining mental health treatment, hormone and thyroid evaluation, personalized medication strategies, and strong social support. By identifying biological contributors earlier and addressing them alongside emotional and practical support, healthcare providers can help more women recover fully—and reduce the risk that postpartum depression becomes a long-term crisis for families.

For some women, postpartum depression is not only a mental health issue—it can also be connected to changes in thyroid function after pregnancy. Conditions such as postpartum thyroiditis or autoimmune thyroid disease can quietly trigger symptoms like fatigue, brain fog, anxiety, and low mood. Because these symptoms overlap so much with postpartum depression, thyroid problems are often missed. Identifying and treating thyroid dysfunction can make a significant difference in how a woman feels and how well she responds to other treatments. 

Paloma Health specializes in comprehensive thyroid care and offers convenient virtual access to clinicians who understand the complex relationship between thyroid hormones, autoimmune disease, and mood symptoms. Through advanced thyroid testing, including markers such as TSH, free T4, and thyroid antibodies, Paloma clinicians can help uncover underlying thyroid issues that may be contributing to postpartum symptoms. If thyroid dysfunction is present, Paloma providers can create a personalized treatment plan and monitor progress closely over time.

For new mothers who are exhausted, overwhelmed, and juggling the demands of caring for a baby, virtual care can make a meaningful difference. Paloma’s online consultations, convenient lab testing, and ongoing thyroid monitoring allow women to get answers and treatment without the added stress of multiple in-person appointments. Addressing thyroid health alongside mental health support can help many women recover faster, regain their energy, and feel more like themselves again.

What is postpartum depression?

Postpartum depression is a form of clinical depression that occurs during pregnancy or within the first year after giving birth. It involves persistent mood symptoms—such as sadness, anxiety, fatigue, and loss of interest in daily life—that last longer than two weeks and interfere with functioning or bonding with the baby.

How is postpartum depression different from the “baby blues”?

Baby blues are very common and typically involve mild mood swings, tearfulness, and irritability that appear a few days after delivery and resolve within about 10 days. Postpartum depression is more intense, lasts longer, and can significantly disrupt a parent’s emotional health and daily life.

What are the most common symptoms of postpartum depression?

Symptoms may include persistent sadness, anxiety, irritability, emotional numbness, difficulty sleeping, appetite changes, fatigue, and trouble concentrating. Some women also feel overwhelmed, disconnected from their baby, or plagued by feelings of guilt or inadequacy.

Can thyroid problems contribute to postpartum depression?

Yes. Thyroid disorders such as postpartum thyroiditis or Hashimoto’s disease can cause symptoms—like fatigue, brain fog, weight gain, and low mood—that overlap with or worsen postpartum depression. Because of this connection, thyroid testing is often recommended when evaluating postpartum mood symptoms.

What is postpartum thyroiditis?

Postpartum thyroiditis is an autoimmune condition in which the immune system temporarily attacks the thyroid after childbirth. It often begins with a short phase of hyperthyroidism followed by a longer hypothyroid phase that can cause fatigue, depression, and weight gain.

How is postpartum depression diagnosed?

Healthcare providers usually diagnose postpartum depression using screening questionnaires such as the Edinburgh Postnatal Depression Scale (EPDS) along with a clinical evaluation. These tools help distinguish true depression from normal adjustment to life with a newborn.

What treatments are available for postpartum depression?

Treatment often includes psychotherapy (such as cognitive behavioral therapy or interpersonal therapy), antidepressant medications, and strong social support. In some cases, a newer medication called zuranolone—taken for 14 days—may be recommended for faster symptom relief.

When should someone seek help for postpartum depression?

If symptoms last longer than two weeks, worsen over time, or interfere with daily life or caring for the baby, it’s important to seek medical help. Immediate help should be sought if there are thoughts of self-harm or harming the baby, as these symptoms require urgent care.